Question 1

What is InMed Pharmaceuticals?

Accepted Answer

InMed Pharmaceuticals is a Company.

Question 2

How often does InMed Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 20 articles.

Question 3

When was InMed Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on May 19, 2026.

Question 4

When was InMed Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jun 15, 2026.

Question 5

What is InMed Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: -10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is InMed Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving InMed Pharmaceuticals?

Accepted Answer

Halper Sadeh LLC Investigates Multiple Mergers (May 19, 2026, 20 articles).

Question 8

How did the "Halper Sadeh LLC Investigates Multiple Mergers" event impact InMed Pharmaceuticals?

Accepted Answer

InMed Pharmaceuticals, Inc. is under investigation by Halper Sadeh LLC concerning its merger with Mentari Therapeutics, Inc., where InMed shareholders are expected to own only 1.51% of the combined company.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.